Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | CA1 | P00915 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GABRP | O00591 | 2/20 | 0.42 |
| ▸ | GABRD | O14764 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.42 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.42 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.42 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.42 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.42 |
| ▸ | GABRE | P78334 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11810502 | 0.89 | ALDH1A1 (0.37) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL23854026 | 0.82 | CA1 (0.45) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL13360245 | 0.82 | LDHA (0.46) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL15793363 | 0.80 | KDM4E (0.57) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL9505997 | 0.80 | NNMT (0.42) | ALDH1A1TSHRKDM4EMAPTHPGD | |
| SCHEMBL17971177 | 0.80 | CES2 (0.31) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL4842186 | 0.78 | CA1 (0.42) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL5336718 | 0.78 | GABRP (0.63) | ALDH1A1GABRPGABRDGABRA1GABRB1 | |
| SCHEMBL426192 | 0.78 | CA1 (0.44) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL5356192 | 0.78 | GABRP (0.63) | ALDH1A1CA1CA2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114349873-B | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-114349873-A | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2024127363-A1 | TYK2 PSEUDOKINASE LIGANDS AND USES THEREOF | ALEMBIC PHARMACEUTICALS LIMITED (IN) | 2024-06-20 | — | — | WO | disclosed |
| CN-114349873-B | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-114349873-B | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2023-03-17 | — | — | CN | disclosed |
| WO-2022268119-A1 | SULFOXIMINE COMPOUND AND USE THEREOF | 南京明德新药研发有限公司 | 2022-12-29 | — | — | WO | disclosed |
| CN-114349873-A | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-114349873-A | High-strength fan bracket for porous module auxiliary control device | 杭州安誉科技有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-106854177-B | A kind of preparation method of 6- chloro-4-hydroxyl pyridine -3- formaldehyde | 苏州健雄职业技术学院 | 2019-10-11 | — | — | CN | disclosed |
| US-20160222014-A1 | COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS | ASANA BIOSCIENCES, LLC (US) | 2016-08-04 | — | — | US | disclosed |
| EP-2975027-A1 | NICOTINAMIDES AS JAK KINASE MODULATORS | Portola Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
| EP-0909270-A4 | — | — | 1999-04-21 | — | — | EP | disclosed |
| EP-0909270-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) | 1999-04-21 | — | — | EP | disclosed |
| WO-1997024327-A1 | PROCESS FOR PREPARING 2,4-DIHYDROXYPYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1997-07-10 | — | — | WO | disclosed |
| US-5155113-A | Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| US-3953428-A | ANTIBACTERIAL | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160222014-A1 | COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS | SRC, PTK2, FYN | ALDH1A1 3377/4885CA1 4192/4885CA2 2316/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.